Todd L. Graybill

Design of amidobenzimidazole STING receptor agonists with systemic activity

Joshi M. Ramanjulu, G. Scott Pesiridis, Jingsong Yang et al. · Nature · 2018 · 803 citations

Systemic Activity, Medicine, Mechanism Of Action +4

Discovery of Thieno[3,2-<i>d</i>]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3

Jeremy S. Disch, Ghotas Evindar, Cynthia H. Chiu et al. · Journal of Medicinal Chemistry · 2013 · 190 citations · Full text

Cell-Based Selection Expands the Utility of DNA-Encoded Small-Molecule Library Technology to Cell Surface Drug Targets: Identification of Novel Antagonists of the NK3 Tachykinin Receptor

Zining Wu, Todd L. Graybill, Xin Zeng et al. · ACS Combinatorial Science · 2015 · 133 citations

Drug Target, Immunology, Molecular Biology +20

Efficient one-pot preparation of 5-substituted-2-amino-1,3,4-oxadiazoles using resin-bound reagents

Frank T. Coppo, Karen A. Evans, Todd L. Graybill et al. · Tetrahedron Letters · 2004 · 111 citations

Organic Chemistry, Pharmacology, Synthesis Method +1

Preparation and evaluation of peptidic aspartyl hemiacetals as reversible inhibitors of interleukin‐l β converting enzyme (ICE)

Todd L. Graybill, Roland E. Dolle, Carla T. Helaszek et al. · International journal of peptide & protein research · 1994 · 60 citations

Pharmaceutical Science, Peptide Scaffold, Immunology +17